NYSE ARCA | ETF
The fund will invest at least 80% of its assets in the component securities of its index and in investments that have economic characteristics that are substantially identical to the component securities of its index and may invest up to 20% of its assets in certain futures, options and swap contracts, cash and cash equivalents as well as in securities not included in the index, but which BFA believes will help the fund track the index.
It is non-diversified.
Top 20 Holdings
| Asset | Name | Sector | Industry | Weight |
|---|---|---|---|---|
| SRRK | Scholar Rock Holding Corp | Healthcare | Biotechnology | 4.62% |
| ARGX | argenx NV ADR | Healthcare | Biotechnology | 4.51% |
| NBIX | Neurocrine Biosciences Inc | Healthcare | Drug Manufacturers - Specialty & Generic | 4.48% |
| ITCI | Intracellular Th | Healthcare | Drug Manufacturers - Specialty & Generic | 4.40% |
| KRTX | Karuna Therapeutics Inc | Healthcare | Biotechnology | 4.29% |
| XENE | Xenon Pharmaceuticals Inc | Healthcare | Biotechnology | 4.28% |
| 326030 | Sk Biopharmaceuticals Co Ltd | Healthcare | Biotechnology | 4.26% |
| BIIB | Biogen Inc | Healthcare | Drug Manufacturers - General | 4.25% |
| DNLI | Denali Therapeutics Inc | Healthcare | Biotechnology | 4.16% |
| SUPN | Supernus Pharmaceuticals Inc | Healthcare | Drug Manufacturers - Specialty & Generic | 4.14% |
| CERE | Cerevel Therapeutics Holdings Inc | Healthcare | Biotechnology | 4.05% |
| ALKS | Alkermes Plc | Healthcare | Drug Manufacturers - Specialty & Generic | 4.02% |
| ACAD | ACADIA Pharmaceuticals Inc | Healthcare | Biotechnology | 4.02% |
| PTCT | PTC Therapeutics Inc | Healthcare | Biotechnology | 3.93% |
| AXNX | Axonics Modulation Technologies Inc | Healthcare | Medical Devices | 3.69% |
| LBPH | Longboard Pharmaceuticals Inc | Healthcare | Biotechnology | 3.66% |
| CPRX | Catalyst Pharmaceuticals Inc | Healthcare | Biotechnology | 3.56% |
| HLUN-B | H Lundbeck A/S | Healthcare | Drug Manufacturers - Specialty & Generic | 3.03% |
| BHVN | Biohaven Pharmaceutical Holding Co Ltd | Healthcare | Biotechnology | 2.93% |
| NEU | Neuren Pharmaceuticals Ltd | Healthcare | Biotechnology | 2.89% |